Estimating postsurgical outcomes of patients with a single hepatocellular carcinoma using gadoxetic acid–enhanced MRI: risk scoring system development and validation
- 18 March 2023
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Radiology
- Vol. 33 (5), 3566-3579
- https://doi.org/10.1007/s00330-023-09539-7
Abstract
Objectives To develop and validate risk scoring systems using gadoxetic acid–enhanced liver MRI features and clinical factors that predict recurrence-free survival (RFS) of a single hepatocellular carcinoma (HCC). Methods Consecutive 295 patients with treatment-naïve single HCC who underwent curative surgery were retrospectively enrolled from two centers. Cox proportional hazard models developed risk scoring systems whose discriminatory powers were validated using external data and compared to the Barcelona Clinic Liver Cancer (BCLC) or American Joint Committee on Cancer (AJCC) staging systems using Harrell’s C-index. Results Independent variables—tumor size (per cm; hazard ratio [HR], 1.07; 95% confidence interval [CI]: 1.02–1.13; p = 0.005), targetoid appearance (HR, 1.74; 95% CI: 1.07–2.83; p = 0.025), radiologic tumor in vein or tumor vascular invasion (HR, 2.59; 95% CI: 1.69–3.97; p < 0.001), the presence of a nonhypervascular hypointense nodule on the hepatobiliary phase (HR, 4.65; 95% CI: 3.03–7.14; p < 0.001), and pathologic macrovascular invasion (HR, 2.60; 95% CI: 1.51–4.48; p = 0.001)—with tumor markers (AFP ≥ 206 ng/mL or PIVKA-II ≥ 419 mAU/mL) derived pre- and postoperative risk scoring systems. The risk scores showed comparably good discriminatory powers in the validation set (C-index, 0.75–0.82) and outperformed the BCLC (C-index, 0.61) and AJCC staging systems (C-index, 0.58; ps < 0.05). The preoperative scoring system stratified the patients into low-, intermediate-, and high-risk for recurrence, whose 2-year recurrence rate was 3.3%, 31.8%, and 85.7%, respectively. Conclusion The developed and validated pre- and postoperative risk scoring systems can estimate RFS after surgery for a single HCC. Key Points • The risk scoring systems predicted RFS better than the BCLC and AJCC staging systems (C-index, 0.75–0.82 vs. 0.58–0.61; ps < 0.05). • Five variables—tumor size, targetoid appearance, radiologic tumor in vein or vascular invasion, the presence of a nonhypervascular hypointense nodule on the hepatobiliary phase, and pathologic macrovascular invasion—combined with tumor markers derived risk scoring systems predicting postsurgical RFS for a single HCC. • In the risk scoring system using preoperatively-available factors, patients were classified into three distinct risk groups, with 2-year recurrence rates in the low-, intermediate-, and high-risk groups being 3.3%, 31.8%, and 85.7% in the validation set.Funding Information
- National Research Foundation of Korea (NRF-2022R1F1A1071409)
This publication has 45 references indexed in Scilit:
- Prognostic Nomograms for Prediction of Recurrence and Survival After Curative Liver Resection for Hepatocellular CarcinomaAnnals of Surgery, 2015
- Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCCHepatology International, 2014
- Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomyJournal of Hepatology, 2013
- Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR ImagingRadiology, 2011
- MRI findings of rapidly progressive hepatocellular carcinomaMagnetic Resonance Imaging, 2010
- Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinomaLiver Transplantation, 2010
- A Novel Prognostic Nomogram Is More Accurate than Conventional Staging Systems for Predicting Survival after Resection of Hepatocellular CarcinomaJournal of the American College of Surgeons, 2008
- Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomesSurgery, 2007
- Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinomaLiver Transplantation, 2005
- Small hepatocellular carcinoma in Child A cirrhotic patients: Hepatic resection versus transplantationLiver Transplantation, 2003